These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 34128960)

  • 1. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics.
    Cheemarla NR; Watkins TA; Mihaylova VT; Wang B; Zhao D; Wang G; Landry ML; Foxman EF
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34128960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated temperature inhibits SARS-CoV-2 replication in respiratory epithelium independently of IFN-mediated innate immune defenses.
    Herder V; Dee K; Wojtus JK; Epifano I; Goldfarb D; Rozario C; Gu Q; Da Silva Filipe A; Nomikou K; Nichols J; Jarrett RF; Stevenson A; McFarlane S; Stewart ME; Szemiel AM; Pinto RM; Masdefiol Garriga A; Davis C; Allan J; Graham SV; Murcia PR; Boutell C
    PLoS Biol; 2021 Dec; 19(12):e3001065. PubMed ID: 34932557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune signatures in the nasopharynx after SARS-CoV-2 infection and links with the clinical outcome of COVID-19 in Omicron-dominant period.
    Cha H; Lee CM; Kim S; Kang CK; Choe PG; Jeon YK; Jo HJ; Kim NJ; Park WB; Kim HJ
    Cell Mol Life Sci; 2024 Aug; 81(1):364. PubMed ID: 39172244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnitude and timing of the antiviral response determine SARS-CoV-2 replication early in infection.
    Cheemarla NR; Watkins TA; Mihaylova VT; Wang B; Zhao D; Wang G; Landry ML; Foxman EF
    medRxiv; 2021 Jan; ():. PubMed ID: 33532783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada.
    Nikiforuk AM; Kuchinski KS; Twa DDW; Lukac CD; Sbihi H; Basham CA; Steidl C; Prystajecky NA; Jassem AN; Krajden M; Patrick DM; Sekirov I
    EBioMedicine; 2021 Apr; 66():103316. PubMed ID: 33819740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Related Susceptibility of Ferrets to SARS-CoV-2 Infection.
    Martins M; Fernandes MHV; Joshi LR; Diel DG
    J Virol; 2022 Feb; 96(3):e0145521. PubMed ID: 34817200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx.
    Vanderboom PM; Mun DG; Madugundu AK; Mangalaparthi KK; Saraswat M; Garapati K; Chakraborty R; Ebihara H; Sun J; Pandey A
    Mol Cell Proteomics; 2021; 20():100134. PubMed ID: 34400346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 innate effector associations and viral load in early nasopharyngeal infection.
    Liou TG; Adler FR; Cahill BC; Cox DR; Cox JE; Grant GJ; Hanson KE; Hartsell SC; Hatton ND; Helms MN; Jensen JL; Kartsonaki C; Li Y; Leung DT; Marvin JE; Middleton EA; Osburn-Staker SM; Packer KA; Shakir SM; Sturrock AB; Tardif KD; Warren KJ; Waddoups LJ; Weaver LJ; Zimmerman E; Paine R
    Physiol Rep; 2021 Feb; 9(4):e14761. PubMed ID: 33625796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiviral state of the cell: lessons from SARS-CoV-2.
    Le Pen J; Rice CM
    Curr Opin Immunol; 2024 Apr; 87():102426. PubMed ID: 38795501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal Gene Expression in Response to SARS-CoV-2 Is Associated with Viral Load.
    Rajagopala SV; Strickland BA; Pakala SB; Kimura KS; Shilts MH; Rosas-Salazar C; Brown HM; Freeman MH; Wessinger BC; Gupta V; Phillips E; Mallal SA; Turner JH; Das SR
    J Virol; 2023 Feb; 97(2):e0147822. PubMed ID: 36656015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-stimulated genes and their antiviral activity against SARS-CoV-2.
    Ortega-Prieto AM; Jimenez-Guardeño JM
    mBio; 2024 Sep; 15(9):e0210024. PubMed ID: 39171921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus infection: An immunologists' perspective.
    De Sanctis JB; García AH; Moreno D; Hajduch M
    Scand J Immunol; 2021 Jun; 93(6):e13043. PubMed ID: 33783027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the Innate Immune Responses for SARS-CoV-2-Human Macrophage Interactions.
    Abdelmoaty MM; Yeapuri P; Machhi J; Olson KE; Shahjin F; Kumar V; Zhou Y; Liang J; Pandey K; Acharya A; Byrareddy SN; Mosley RL; Gendelman HE
    Front Immunol; 2021; 12():741502. PubMed ID: 34671355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TMPRSS2-mediated SARS-CoV-2 uptake boosts innate immune activation, enhances cytopathology, and drives convergent virus evolution.
    Qu B; Miskey C; Gömer A; Kleinert RDV; Ibanez SC; Eberle R; Ebenig A; Postmus D; Nocke MK; Herrmann M; Itotia TK; Herrmann ST; Heinen N; Höck S; Hastert FD; von Rhein C; Schürmann C; Li X; van Zandbergen G; Widera M; Ciesek S; Schnierle BS; Tarr AW; Steinmann E; Goffinet C; Pfaender S; Locker JK; Mühlebach MD; Todt D; Brown RJP
    Proc Natl Acad Sci U S A; 2024 Jun; 121(23):e2407437121. PubMed ID: 38814864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
    Ziegler CGK; Miao VN; Owings AH; Navia AW; Tang Y; Bromley JD; Lotfy P; Sloan M; Laird H; Williams HB; George M; Drake RS; Christian T; Parker A; Sindel CB; Burger MW; Pride Y; Hasan M; Abraham GE; Senitko M; Robinson TO; Shalek AK; Glover SC; Horwitz BH; Ordovas-Montanes J
    Cell; 2021 Sep; 184(18):4713-4733.e22. PubMed ID: 34352228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of L-Dopa decarboxylase expression in SARS-CoV-2 infection and its association with the interferon-inducible ACE2 isoform.
    Mpekoulis G; Frakolaki E; Taka S; Ioannidis A; Vassiliou AG; Kalliampakou KI; Patas K; Karakasiliotis I; Aidinis V; Chatzipanagiotou S; Angelakis E; Vassilacopoulou D; Vassilaki N
    PLoS One; 2021; 16(6):e0253458. PubMed ID: 34185793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
    Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
    J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.